The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19
Status:
Not yet recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The study aims to test whether Ivermectin would decrease mortality and reduces chances of
getting infected with corona virus, improve management of clinical symptoms and reduce length
of stay in ICU and transition probabilities to ICU (ventilator).